THIRUVANANTHAPURAM: The State Drugs Control Department has banned the sale and distribution of various batches of medicines, after those were found to be of poor quality in an analysis at Drug Testing Laboratory, Thiruvananthapuram. The brand, batch number and the manufacturer’s name of the banned batches are stated below:
FOLIMAX (Folic Acid Tablets IP 5mg) NT 4050304 - Dr.Kumar’s Pharmaceuticals, Bilaspur; CARMISOL FORTE 100 ml LRM 003 - Restech Pharmaceuticals, Puducherry; CARMISOL 100 ml LCA 005 - Restech Pharmaceuticals, Puducherry; CARMISOL FORTE 100 ml LRM 004 - Restech Pharmaceuticals, Puducherry; CARMISOL 100 ml LCA 003 - Restech Pharmaceuticals, Puducherry; CARMISOL 100 ml 2056 - Bulwark Pharmaceuticals, Chennai; PANT 40 (Pantoprazole Tablets) TNOT 601 - Tanmed Pharmaceuticals, Chennai; TOPP 40 (Pantoprazole Tablets) TP 06 Mepromax Life Science Pvt. Ltd., Dehradun, Uttarkhand; GRA 82 (Aspirin IP 82mg) GW 1901 - Glenwell Pharma, Puducherry, BETACIL8 (Betahistine Tablets IP 8mg) BEHS 14 - C.I.Laboratories, Kolkata; BETACIL 8 (Betahistine Tablets IP 8mg) BEHS 11 - C.I.Laboratories, Kolkata; RABIFEEL 20 Tablets (Rabeprazole Sodium IP 20mg) 4245 - Tee&Tee Healthcare, Himachal Pradesh; TUMCEF 500 JM 832C2823- J M Remedies, Himachal Pradesh; METAR (Metoprolol Tartrate Tablets IP) CN 14002- Ortinn Laboratories Ltd., Medak; OMEPRAZOLE Capsule IP 20mg OZC 02-48 - Unicure India Ltd., Noida; OMEPRAZOLE Capsule IP 20 mg OZC 02-17 - Unicure India Ltd., Noida; LITHIUM CARBONATE Tablets IP 300 mg LCT 02-03 - Unicure India Ltd., Noida; ZEDIRON Tablets (Ferrous Ascoarbate &Folic Acid Tablets) D 40549 - Arion Healthcare, Himachal Pradesh; SIXER Ointment 10 - Darwin Formulations Pvt. Ltd., Andhra Pradesh; MYSOLON (Prednisolone IP 10 mg) 140923 - Modi Lifecare Industries Ltd., Gujarat; SALWEET SYRUP 1434 - Saar Biotech, Solan; ORPRO RABEPRAZOLE SODIUM TABLETS IP ORO 045 -M M Healthcare Pvt. Ltd., Himachal Pradesh; PARAYES 500 (Paracetamol Tab IP) ZDT 1762 -ZEE Laboratories Ltd., Paonta Sahib.
Those in possession of the such medicines should return them to distributors and inform the Drugs Control Office.